Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Orally disintegrating and oral standard olanzapine tablets similarly elevate the homeostasis model assessment of insulin resistance index and plasma triglyceride levels in 12 healthy men: a randomized crossover study.

Vidarsdottir S, Vlug P, Roelfsema F, Frölich M, Pijl H.

J Clin Psychiatry. 2010 Sep;71(9):1205-11. doi: 10.4088/JCP.08m04654yel. Epub 2010 Apr 20.

PMID:
20441717
2.

Olanzapine shifts the temporal relationship between the daily acrophase of serum prolactin and cortisol concentrations rhythm in healthy men.

Vidarsdottir S, Roelfsema F, Frolich M, Pijl H.

Psychoneuroendocrinology. 2009 Jun;34(5):705-12. doi: 10.1016/j.psyneuen.2008.11.008. Epub 2009 Jan 7.

PMID:
19131173
3.

Short-term treatment with olanzapine does not modulate gut hormone secretion: olanzapine disintegrating versus standard tablets.

Vidarsdottir S, Roelfsema F, Streefland T, Holst JJ, Rehfeld JF, Pijl H.

Eur J Endocrinol. 2010 Jan;162(1):75-83. doi: 10.1530/EJE-09-0433. Epub 2009 Sep 24.

4.

Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study.

Smith RC, Lindenmayer JP, Davis JM, Kelly E, Viviano TF, Cornwell J, Hu Q, Khan A, Vaidhyanathaswamy S.

J Clin Psychiatry. 2009 Nov;70(11):1501-13. doi: 10.4088/JCP.08m04446yel. Epub 2009 Oct 6.

PMID:
19814947
5.

The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.

Fell MJ, Anjum N, Dickinson K, Marshall KM, Peltola LM, Vickers S, Cheetham S, Neill JC.

Psychopharmacology (Berl). 2007 Oct;194(2):221-31. Epub 2007 Jun 21.

PMID:
17581744
6.

Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.

Melkersson KI, Hulting AL, Brismar KE.

J Clin Psychiatry. 2000 Oct;61(10):742-9.

PMID:
11078035
7.

Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Henderson DC, Copeland PM, Borba CP, Daley TB, Nguyen DD, Cagliero E, Evins AE, Zhang H, Hayden DL, Freudenreich O, Cather C, Schoenfeld DA, Goff DC.

J Clin Psychiatry. 2006 May;67(5):789-97.

PMID:
16841629
8.

Effect of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin.

Sneddon AA, Tsofliou F, Fyfe CL, Matheson I, Jackson DM, Horgan G, Winzell MS, Wahle KW, Ahren B, Williams LM.

Obesity (Silver Spring). 2008 May;16(5):1019-24. doi: 10.1038/oby.2008.41. Epub 2008 Mar 6.

9.

Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions.

Birkenaes AB, Birkeland KI, Friis S, Opjordsmoen S, Andreassen OA.

J Clin Psychopharmacol. 2009 Apr;29(2):109-16. doi: 10.1097/JCP.0b013e31819b95fc.

PMID:
19512971
10.

Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia.

Hosojima H, Togo T, Odawara T, Hasegawa K, Miura S, Kato Y, Kanai A, Kase A, Uchikado H, Hirayasu Y.

J Psychopharmacol. 2006 Jan;20(1):75-9. Epub 2005 Oct 4.

PMID:
16204328
11.

Olanzapine induces insulin resistance: results from a prospective study.

Ebenbichler CF, Laimer M, Eder U, Mangweth B, Weiss E, Hofer A, Hummer M, Kemmler G, Lechleitner M, Patsch JR, Fleischhacker WW.

J Clin Psychiatry. 2003 Dec;64(12):1436-9.

PMID:
14728104
12.

Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.

Sharma PK, Bhansali A, Sialy R, Malhotra S, Pandhi P.

Clin Endocrinol (Oxf). 2006 Dec;65(6):722-8.

PMID:
17121522
13.
14.
15.

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC.

Arch Gen Psychiatry. 2005 Jan;62(1):19-28.

PMID:
15630069
16.
17.

Effect of olanzapine orally disintegrating tablet versus oral standard tablet on body weight in patients with schizophrenia: a randomized open-label trial.

Kusumi I, Honda M, Uemura K, Sugawara Y, Kohsaka M, Tochigi A, Koyama T.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):313-7. doi: 10.1016/j.pnpbp.2011.11.004. Epub 2011 Nov 15.

PMID:
22119746
18.
19.

A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.

Albaugh VL, Singareddy R, Mauger D, Lynch CJ.

PLoS One. 2011;6(8):e22662. doi: 10.1371/journal.pone.0022662. Epub 2011 Aug 9.

20.

Serum free Fatty acids and glucose metabolism, insulin resistance in schizophrenia with chronic antipsychotics.

Wang CJ, Zhang ZJ, Sun J, Zhang XB, Mou XD, Zhang XR, Shang XF, Zhang TQ.

Biol Psychiatry. 2006 Dec 15;60(12):1309-13. Epub 2006 May 2.

PMID:
16650386
Items per page

Supplemental Content

Write to the Help Desk